Artificial intelligence is poised to play an increasingly prominent role in medicine and healthcare because of advances in computing power, learning algorithms, and availability of large datasets sourced from medical records and wearable health monitors.
The World Health Organization reports say that in the year 2014, 8.5% of adults aged 18 years and older had diabetes. Similarly, in 2019, diabetes was the direct cause of 1.5 million deaths and 48% of all deaths in the world.
About 422 million people worldwide have diabetes, the majority living in low-and middle-income countries, and 1.5 million deaths are directly attributed to diabetes each year.
Researchers all over the world have been trying to ease the process of detection and treatment of diabetes through various researches.
Technical giant Hitachi has put a step forward by collaborating with the University of Utah Health and the non-profit health informatics research organization Regenstrief Institute to develop and test a new artificial intelligence method that supports care for patients with type 2 diabetes and the one who require complex drug treatment.
A study was carried out by this AI, where HER data across Utah and United States were analyzed and learned generalized treatment patterns and clinical outcomes among type 2 diabetes patients with similar characteristicsA study was carried out by this AI, where HER data across Utah and United States were analyzed and learned generalized treatment patterns and clinical outcomes among type 2 diabetes patients with similar characteristics. In the following stage, it organized patients into disease state groups and predicted the range of potential health outcomes depending on the treatment options.
As published in the Journal of Biomedical Informatics, it was seen that the algorithm was able to support medication selection for over 83% of patients, even when two or more medications were used.
According to the International Diabetes Federation, more than 500 million people in the world are at risk of getting type 2 diabetes. In this context, Hitachi said that a small portion of them require multiple medications to control blood sugar and avoid serious complications like vision loss and kidney disease. The pattern learned by the new AI method developed by Hitachi and its partners can be used to assist clinicians in determining an optimal drug regimen for a specific patient.
"We want to help the diabetes patients requiring complex treatments to receive the right treatment plan from their doctors after checking the efficacy of various drug combinations", said the research team behind the AI technology.
In recent years, more AI-enabled tools for diabetes management have been approved for commercial rollouts.